1133

The trend of cancer incidences is one of the key questions for developing critical illness (CI) and cancer insurance products with a sustainable price.

SCOR announces the publication of its interim financial report for the six months ended 30 June 2015

Over 35 million people in the world are HIVpositive. Again, as long as treatment and regular medical follow-up show an absence of immunosuppression, some of these people can be offered life cover.

Réhalto’s approach to managing employees on sick leave is holistic and focuses on the person within his/her work and social environment.

In the run up to the Climate conference due to be held in Paris in 2015 (COP 21), the Toulouse School of Economics, the Geneva Association and the SCOR Corporate Foundation for Science will be holding an international

SCOR delivers high quality net income of EUR 175 million and annualized ROE of 12.1%.

SCOR Global Life Embedded Value increases 6.2% to EUR 4.7 billion in 2014 (EUR 25.5 per share), continuing to provide the Group with significant earnings and strong capital repatriation

SCOR delivers high quality net income of EUR 175 million and annualized ROE of 12.1%

SCOR delivers high quality net income of EUR 175 million and annualized ROE of 12.1%